ESLA earnings: next date and EPS history
Estrella Immunopharma, Inc.
Is ESLA halal? — screening resultHalal
Next report
The next report date isn't known yet — it will appear here once the company announces it.
At a glance
Over the last 1 quarters: 1 beats and 0 misses on EPS. Median surprise: +44.4%.
Around the report the price moved ±8.6% on average (largest ±19.6%); up 3 times, down 5 times.
EPS: estimate vs actual
Two bars per quarter: grey — analysts' estimate, coloured — actual EPS (green — beat, red — miss).
Post-earnings price move
Change from the close before the report to the close after it.
Last 8 quarters
| Report date | Quarter ending | Estimate | Actual | Surprise | Result | Price move |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | Jun 2026 | −$0.09 | −$0.05 | +44.4% | Beat | −2.3%Aug 12, 2026 → Aug 14, 2026 |
| May 15, 2026 | Mar 2026 | — | −$0.05 | — | No estimate | −7.0%May 14, 2026 → May 18, 2026 |
| Mar 17, 2026 | Dec 2025 | — | −$0.01 | — | No estimate | −7.7%Mar 16, 2026 → Mar 18, 2026 |
| Nov 12, 2025 | Sep 2025 | — | −$0.13 | — | No estimate | −12.3%Nov 11, 2025 → Nov 13, 2025 |
| Aug 11, 2025 | Jun 2025 | — | −$0.15 | — | No estimate | +5.1%Aug 8, 2025 → Aug 12, 2025 |
| May 14, 2025 | Mar 2025 | — | −$0.06 | — | No estimate | −8.7%May 13, 2025 → May 15, 2025 |
| Nov 14, 2024 | Sep 2024 | — | −$0.09 | — | No estimate | +6.0%Nov 13, 2024 → Nov 15, 2024 |
| Sep 27, 2024 | Jun 2024 | — | −$0.13 | — | No estimate | +19.6%Sep 26, 2024 → Sep 30, 2024 |
EPS is the adjusted figure; the estimate is the consensus before the report. Price move: from the close of the trading day before the report to the close of the trading day after it — the two-day window covers both before-open and after-close reports.
Don't miss ESLA's next report
Add the stock to your watchlist — 2 days before the report you get a Telegram and on-site reminder with the expected EPS, the previous surprise and your own notes. The dashboard has ESLA's chart, metrics and signals.
No card required.
How to read this page
EPS (earnings per share) is the company's quarterly net income divided by its share count. The market doesn't judge it in isolation but against the analysts' estimate — the consensus.
An earnings surprise is how far the actual figure landed from the estimate. Some companies beat consistently, but that doesn't guarantee the next quarter will be the same.
The price reaction doesn't always match the result: a stock can fall on a good EPS print because the market also weighs revenue, guidance and margins. The move the options market prices in before the report is the expected move; a sustained one-directional move afterwards is post-earnings drift.
Frequently asked questions
- When does ESLA report earnings next?
- Estrella Immunopharma, Inc. hasn't announced its next report date yet. Companies usually announce it 2–4 weeks before the report.
- Has ESLA beaten estimates recently?
- Over the last 1 quarters Estrella Immunopharma, Inc. beat the EPS estimate 1 times and missed 0 times. Median surprise: +44.4%.
- How much does ESLA stock usually move after earnings?
- Over the last 8 reports ESLA moved ±8.6% on average around the report (from the close before to the close after), with the largest move at ±19.6%. This is history, not a forecast for the next report.
- What is the EPS estimate (consensus)?
- The consensus is the average of the EPS forecasts of the analysts covering the company. The report is measured against exactly this number: above it is a beat, below it is a miss.
- Where does this data come from?
- Report dates, EPS estimates and actuals come from the Nasdaq earnings calendar, which we have archived day by day since January 1, 2024. The price move is computed from daily closing prices stored in Limitup's database. Revenue estimates are not shown — free sources don't cover every company reliably.
For information only, not investment advice. Past earnings results don't guarantee future results. Sources can contain errors — check the company's official release before an important decision.